PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.55%
Positive revenue growth while NXPI is negative. John Neff might see a notable competitive edge here.
10.73%
Gross profit growth above 1.5x NXPI's 0.37%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
18.30%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
18.21%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
5.92%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
6.06%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
6.19%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.40%
Share reduction while NXPI is at 0.34%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.39%
Reduced diluted shares while NXPI is at 0.28%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.00%
Dividend growth of 0.00% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
15.35%
Positive OCF growth while NXPI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
14.67%
Positive FCF growth while NXPI is negative. John Neff would see a strong competitive edge in net cash generation.
55.93%
Similar 10Y revenue/share CAGR to NXPI's 55.51%. Walter Schloss might see both firms benefiting from the same long-term demand.
27.00%
5Y revenue/share CAGR at 50-75% of NXPI's 48.05%. Martin Whitman would worry about a lagging mid-term growth trajectory.
20.87%
3Y revenue/share CAGR 1.25-1.5x NXPI's 15.99%. Bruce Berkowitz might see better product or regional expansions than the competitor.
47.63%
10Y OCF/share CAGR under 50% of NXPI's 180.58%. Michael Burry would worry about a persistent underperformance in cash creation.
55.81%
5Y OCF/share CAGR above 1.5x NXPI's 20.58%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
27.49%
3Y OCF/share CAGR similar to NXPI's 29.49%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
150.27%
Positive 10Y CAGR while NXPI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
171.55%
5Y net income/share CAGR 1.25-1.5x NXPI's 140.05%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
66.59%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
34.68%
Equity/share CAGR of 34.68% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
10.06%
Below 50% of NXPI's 811.03%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.24%
Below 50% of NXPI's 771.55%. Michael Burry suspects a serious short-term disadvantage in building book value.
526.04%
Dividend/share CAGR of 526.04% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
192.90%
Dividend/share CAGR of 192.90% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.12%
3Y dividend/share CAGR of 66.12% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
9.87%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
5.64%
Inventory growth well above NXPI's 2.97%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.88%
Asset growth above 1.5x NXPI's 0.06%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.05%
75-90% of NXPI's 1.31%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
6.70%
Debt growth far above NXPI's 0.60%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.44%
R&D growth drastically higher vs. NXPI's 3.81%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.